|
|
Volumn 17, Issue 6, 1994, Pages 522-526
|
|
Ondansetron and dexamethasone versus standard combination antiemetic therapy: A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METOCLOPRAMIDE;
ONDANSETRON;
ORPHENADRINE;
SEROTONIN ANTAGONIST;
ADULT;
AGED;
ANTIEMETIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
EXTRAPYRAMIDAL SYMPTOM;
FEMALE;
HEADACHE;
HISTOLOGY;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
VOMITING;
|
|
EID: 0028151391
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-199412000-00015 Document Type: Article |
|
Times cited : (28)
|
|
References (0)
|
